Healthcare

Blue Cell Therapeutics appoints highly experienced pharma and biotech executive Olav Hellebø as Chairman of the Board of Directors

COPENHAGEN, Denmark, Sept. 4, 2025, 03:30 GMT-04

Blue-Cell-Therapeutic

Read full article →

Myelofibrosis Market is Going to Grow at a CAGR of 9% in the Next Ten Years (2025-2034) | DelveInsight

LAS VEGAS, Sept. 3, 2025, 17:31 GMT-04

DELVEINSIGHT-BUSINESS

Read full article →

GMP Cell Therapy Consumables Market to Reach USD 114.4 Million by 2035, with CAGR 28.9% Driven by Advanced Cell Therapy and Biopharmaceutical Innovation | Vantage Market Research

NEW YORK, Sept. 3, 2025, 10:30 GMT-04

VANTAGE-MARKET

Read full article →

Swine Influenza Vaccines Market Projected to Reach USD 750 Billion by 2033 Driven by Advancements in Animal Health, Rising Swine Population - Market Research Intellect

LEWES, Del., Sept. 3, 2025, 10:15 GMT-04

MR-INTELLECT

Read full article →

Rotavirus Vaccine Market Is Projected to Reach USD 3.5 Billion by 2033 Driven by Rising Immunization Programs and Increasing Healthcare Awareness - Market Research Intellect

LEWES, Del., Sept. 3, 2025, 10:15 GMT-04

MR-INTELLECT

Read full article →

Point of Care Molecular Diagnostics Market worth US$7.09 billion by 2030 with 10.5% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 3, 2025, 10:01 GMT-04

MARKETSANDMARKETS

Read full article →

Zero Candida Technologies Reports Financial Results for Three and Six Months Ended June 30, 2025 and Provides Business Update

VANCOUVER, BC, Sept. 3, 2025, 09:00 GMT-04

ZERO-CANDIDA-sales

Read full article →

Diabetic Foot Ulcers Market Size to Reach USD 9.25 Billion with 6.1% CAGR by 2033, Report by DataM Intelligence

AUSTIN, Texas and TOKYO, Sept. 3, 2025, 06:50 GMT-04

DataMIntelligence

Read full article →

Biotechnology Market is Estimated to Reach USD 6.64 Trillion by 2032 | SkyQuest Technology Consulting

WESTFORD, Mass., Sept. 3, 2025, 06:30 GMT-04

SKYQUEST-TECHNOLOGY

Read full article →

Resolution Therapeutics announces first patient dosed in Phase I/II EMERALD study of RTX001 for the treatment of end-stage liver disease

EDINBURGH, Scotland and LONDON, Sept. 3, 2025, 03:30 GMT-04

Resolution-RTX001

Read full article →

Terumo Neuro Launches Aneurysm Treatment Alliance in EMEA to Advance Physician Collaboration and Aneurysm Care

MARSEILLE, France, Sept. 3, 2025, 03:00 GMT-04

TerumoLaunch-Aneurysm

Read full article →

Rolling sBLA initiated to the U.S. FDA for Leqembi® Iqlik™ (lecanemab-irmb) as a subcutaneous starting dose for the treatment of early Alzheimer's disease under Fast Track status

STOCKHOLM, Sept. 3, 2025, 23:06 GMT-04

BIOARCTIC

Read full article →

Clostridioides difficile Infection Market Forecasts by DelveInsight Signal Groundbreaking Growth at a CAGR of 13.5% in the 7MM during the Forecast Period (2025-2034)

LAS VEGAS, Sept. 2, 2025, 17:31 GMT-04

DELVEINSIGHT

Read full article →

3-minute EEG Test Reliably Detects Memory Impairment, Enabling Earlier Alzheimer's Diagnosis

BELFAST, Northern Ireland, Sept. 2, 2025, 17:23 GMT-04

CUMULUS

Read full article →

Minimally Invasive Surgery Market worth US$199.30 billion by 2030 with 16.1% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 2, 2025, 10:01 GMT-04

MarketsandMarkets

Read full article →

Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands

VANCOUVER, BC, Sept. 2, 2025, 09:30 GMT-04

Equity-Insider

Read full article →

European Infection Control Market worth US$20.58 billion by 2030 with 6.6% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 2, 2025, 05:30 GMT-04

MARKETSANDMARKETS

Read full article →

Nuffield Holdings Welcomes Strategic Shareholders to Drive Next Phase of Regional Growth

SINGAPORE, Sept. 2, 2025, 04:44 GMT-04

Nuffield

Read full article →

Karo Healthcare strengthens its portfolio of skin health brands in Northern Europe

STOCKHOLM, Sept. 2, 2025, 03:16 GMT-04

KARO-Portfolio

Read full article →

Global Cancer Diagnostics Market to Hit USD 215 Billion by 2035, Growing at 6.35% CAGR | Vantage Market Research

NEW YORK, Sept. 2, 2025, 02:20 GMT-04

VANTAGE-MARKET

Read full article →